Increased susceptibility of male rats to kanamycin-induced cochleotoxicity

Hearing Research

Volumn 128, Issue 1-2, 1999, Pages 75-79

  Mills, Charles D ^a   Loos, Benjamin M ^a   Henley, Charles M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Aminoglycoside; Distortion product otoacoustic emission; Gender; Ototoxicity; Sex

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; KANAMYCIN; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COCHLEA INJURY; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISTORTION PRODUCT OTOACOUSTIC EMISSION; DRUG INDUCED DISEASE; FEMALE; HAIR CELL; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL; RAT; SEX DIFFERENCE;

ANIMALS; COCHLEA; DIFFERENTIAL THRESHOLD; DRUG RESISTANCE; ELECTROPHYSIOLOGY; FEMALE; HAIR CELLS, OUTER; KANAMYCIN; MALE; OTOACOUSTIC EMISSIONS, SPONTANEOUS; RATS; RATS, LONG-EVANS; SEX CHARACTERISTICS; TIME FACTORS;

EID: 0032911251     PISSN: 03785955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5955(98)00190-7     Document Type: Article

References (14)

1. Astbury P.J., Read N.G. Kanamycin induced ototoxicity in the laboratory rat. Arch. Toxicol. 50:1982;267-278.
2. Barza M., Lauermann M.W., Tally F.P., Gorbach S.L. Prospective, randomized trial of netilmicin and amikacin, with emphasis on eighth-nerve toxicity. Antimicrob. Agents Chemother. 17:1980;707-714.
3. Bennett W.M., Parker R.A., Elliott W.C., Gilbert D.N., Houghton D.C. Sex-related differences in the susceptibility of rats to gentamicin nephrotoxicity. J. Infect. Dis. 145:1982;370-373.
4. Brown R.D., Henley C.M., Penny J.E., Kupetz S. Link between functional and morphological changes in the inner ear: functional changes produced by ototoxic agents and their interactions. Arch. Toxicol. Suppl. 8:1985;240-250.
5. Carlier E., Pujol R. Supra-normal sensitivity to ototoxic antibiotic of the developing rat cochlea. Arch. Otorhinolaryngol. 226:1980;129-133.
6. D'Alonzo B.J., Cantor A.B. Ototoxicity: Etiology and Issues. J. Family Pract. 16:1983;489-494.
7. Hawkins, J.E., 1976. Drug ototoxicity. In: Keidel, W.D., Neff, W.D. (Eds.), Handbook of Sensory Physiology, Vol. 5, Springer, Berlin, pp. 707-748.
8. Henley C.M., Rybak L.P. Ototoxicity in developing mammals. Brain Res. Rev. 20:1995;68-90.
9. Henley C.M., Weatherly R.A., Martin G.K., Lonsbury-Martin B.L. Sensitive developmental periods for kanamycin ototoxic effects on distortion product otoacoustic emissions. Hear. Res. 98:1996;93-103.
10. Henley C.M., Weatherly R.A., Ou C.-N., Brown R.D. Pharmacokinetics of kanamycin in the developing rat. Hear. Res. 99:1996;85-90.
11. Lautermann J., McLaren J., Schacht J. Glutathione protection against gentamicin ototoxicity depends on nutritional status. Hear. Res. 86:1995;15-24.
12. Lenoir M., Marot M., Uziel A. Comparative ototoxicity of four aminoglycoside antibiotics during the critical period of cochlear development in the rat. Acta Otolaryngol. Suppl. 405:1983;1-16.
13. Prieve B.A., Yanz J.L. Age-dependent changes in susceptibility to ototoxic hearing loss. Acta Otolaryngol. 98:1984;428-438.
14. Pujol R. Periods of sensitivity to antibiotic treatment. Acta Otolaryngol. Suppl. 429:1986;29-33.